Skip to main content
Clinical Trials/CTRI/2023/04/051971
CTRI/2023/04/051971
Not yet recruiting
未知

A Randomised Comparative Study To Compare The Effectiveness of Centesimal Versus Fifty Millesimal Scale In The Management of Polycystic Ovarian Syndrome

ehru Homoeopathic Medical College and Hospital University of Delhi0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Sponsor
ehru Homoeopathic Medical College and Hospital University of Delhi
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ehru Homoeopathic Medical College and Hospital University of Delhi

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of reproductive age group(18\-40 years)
  • 2\. Patients with oligomenorrhea (intermenstrual period of more than 35 days for 3 consecutive cycles) or amenorrhea for more than 3 months(2 years after menarche)
  • 3\. Patients with ultrasound findings of Polycystic ovary(the polycystic ovary had atleast one of the following: either 12 or more follicles measuring 2\-9 mm in diameter or increase ovarian volume more than 10 cubic centimeter). Only one ovary fitting this definition or single occurance of one of the above criteria is sufficient to define polycystic ovary
  • 4\. Patients will clinical evidence of hirsutism
  • 5\. Patients willing to provide written informed consent

Exclusion Criteria

  • 1\. Pregnant and lactating women
  • 2\. Cases complicated with Cushing disease, hyperprolactinaemia, endometriosis and malignancies etc
  • 3\. Cases with adrenal hyperplasia and adrenal tumour
  • 4\. Ovarian tumour
  • 5\. Significant renal impairment
  • 6\. Patients who are terminally ill, under immunosuppressive treatment or self reported immunocompromised state
  • 7\. Diagnosed case of mental illness/psychiatric/ life threatening illness affecting quality of life/ any organ failure
  • 8\. Substance abuse and/or dependence
  • 9\. Patients who are unwilling to take part or not giving consent to join the study or unable to read patient information sheet

Outcomes

Primary Outcomes

Not specified

Similar Trials